Abenavoli Ludovico, Scarlata Giuseppe Guido Maria, Paravati Maria Rosaria, Boccuto Luigi, Luzza Francesco, Scarpellini Emidio
Department of Health Sciences, University "Magna Graecia", 88100 Catanzaro, Italy.
School of Nursing, Healthcare Genetics Program, Clemson University, Clemson, SC 29634, USA.
Biomedicines. 2023 Jun 23;11(7):1792. doi: 10.3390/biomedicines11071792.
Liver transplantation (LT) is the treatment of choice for patients with cirrhosis, decompensated disease, acute liver failure, and hepatocellular carcinoma (HCC). In 3-25% of cases, an alarming problem is acute and chronic cellular rejection after LT, and this event can lead to the need for new transplantation or the death of the patient. On the other hand, gut microbiota is involved in several mechanisms sustaining the model of the "gut-liver axis". These include modulation of the immune response, which is altered in case of gut dysbiosis, possibly resulting in acute graft rejection. Some studies have evaluated the composition of the gut microbiota in cirrhotic patients before and after LT, but few of them have assessed its impact on liver rejection. This review underlines the changes in gut microbiota composition before and after liver transplantation, hypothesizing possible immune mechanisms linking dysbiosis to transplantation rejection. Evaluation of changes in the gut microbiota composition in these patients is therefore essential in order to monitor the success of LT and eventually adopt appropriate preventive measures.
肝移植(LT)是肝硬化、失代偿性疾病、急性肝衰竭和肝细胞癌(HCC)患者的首选治疗方法。在3%-25%的病例中,一个令人担忧的问题是肝移植后的急性和慢性细胞排斥反应,这一事件可能导致需要再次移植或患者死亡。另一方面,肠道微生物群参与了维持“肠-肝轴”模型的多种机制。其中包括免疫反应的调节,在肠道生态失调的情况下,免疫反应会发生改变,可能导致急性移植物排斥反应。一些研究评估了肝硬化患者肝移植前后肠道微生物群的组成,但很少有研究评估其对肝排斥反应的影响。本综述强调了肝移植前后肠道微生物群组成的变化,推测了将生态失调与移植排斥反应联系起来的可能免疫机制。因此,评估这些患者肠道微生物群组成的变化对于监测肝移植的成功与否并最终采取适当的预防措施至关重要。